Specialty Pharmacy

Emergency room physician finds hope in new treatments during long battle with lung cancer.

Top articles of the week on Specialty Pharmacy Times.

Nearly 2 million cancer deaths have been avoided over last 25 years.

Measured and unmeasured costs can have a significant impact on outcomes for patients with cancer.

Unsanitary living conditions promote spread of the virus.

Disappointing sales were blamed on prior authorization, the FDA label restrictions, and the need for spirometry before doctors could write prescriptions.

Patients with certain diabetic foot ulcers now have a new treatment option.

More than 40 members of the US House of Representatives have expressed support for greater pharmacist roles in improvements made to Medicare Part D's medication therapy management (MTM) program.

By infecting 5% to 10% of the US population each year, influenza consumes $87.1 billion.

Vitamin D3 found to aid immune response regulation among patients with MS.

Treatment with Imbruvica found to improve overall response rate.

Open Payments database sheds light on payments from pharmaceutical and medical device companies to physicians.

Treatment shows the potential to turn metastatic breast tumors into low-grade tumors.

Prescription drug cost-sharing requirements may better inform consumer selection.

Prognosis markers may help project clinical outcomes for CRC patients.

While the prevalence of problems paying medical bills may be greater in certain groups compared with others, almost anyone can experience difficulty paying medical bills, according to the results of a survey from Kaiser Family Foundation/New York Times.

Study finds adoption of Medicaid expansion could reduce disparities in breast cancer screening.

Phase 3 study results show high efficacy and improved renal and bone safety parameters with tenofovir alafenamide regimen.

Researchers achieve promising first step in new HIV treatment approach.

David D'Altorio, PharmD, senior vice president of health services at MedImpact Healthcare Systems, discusses methods to improve communication among drug manufacturers and health care providers.

Research compares multidimensional approaches with uni-dimensional interventions.

Antibiotics suppress bacterial growth but may facilitate fungi growth.

Despite the advent of a multitude of non-insulin therapies, insulin maintains its place in diabetes management.

Sofosbuvir and velpastavir combination being evaluated for hepatitis C genotypes 1-6.

Targeted intervention programs could offer significant benefits in HCV prevention.

Palbociclib has been found effective inhibiting the mobilization of enzymes that contribute to the rapid division of tumor cells.

Major drug companies are starting to make cheap versions of blockbuster hepatitis C drugs available to people in poor and many middle-income nations.

Sprouty 2 gene works differently in colorectal cancer than in other types of cancers.